Follicular delivery of spironolactone via nanostructured lipid carriers for management of alopecia

Spironolactone (SL) is a US Food and Drug Administration-approved drug for the treatment of hypertension and various edematous conditions. SL has gained a lot of attention for treating androgenic alopecia due to its potent antiandrogenic properties. Recently, there has been growing interest for foll...

Descripción completa

Detalles Bibliográficos
Autores principales: Shamma, Rehab Nabil, Aburahma, Mona Hassan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251754/
https://www.ncbi.nlm.nih.gov/pubmed/25473283
http://dx.doi.org/10.2147/IJN.S73010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251754/
https://www.ncbi.nlm.nih.gov/pubmed/25473283
http://dx.doi.org/10.2147/IJN.S73010

Ejemplares similares